conduct
seri
polymeras
chain
reaction
pcr
order
detect
bacteria
speci
virus
speci
middl
ear
fluid
mef
nasopharynx
nph
children
acut
otiti
media
aom
n
bacteri
viral
nucleic
acid
detect
mef
patient
respect
preval
follow
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
streptococcu
pyogen
moraxella
catarrhali
rhinoviru
adenoviru
overal
rate
pcrposit
specimen
bacteri
pathogen
time
higher
compar
cultur
result
rate
pcrposit
result
distribut
pathogen
nph
similar
mef
nph
pcr
result
variabl
posit
predict
valu
high
neg
predict
valu
predict
mef
find
result
indic
nph
pcr
could
practic
tool
examin
respiratori
pathogen
children
acut
infect
acut
otiti
media
aom
one
common
pediatr
infect
high
rate
medic
visit
antibiot
prescript
lieberth
et
al
bacteri
speci
includ
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
streptococcu
pyogen
predomin
among
aom
pathogen
respons
etiolog
verifi
case
vergison
respiratori
virus
like
human
rhinoviru
hrv
adenoviru
adv
respiratori
syncyti
viru
rsv
other
occasion
found
middl
ear
howev
role
independ
primari
aomcaus
agent
remain
discuss
chonmaitre
et
al
heikkinen
chonmaitre
noksokoivisto
et
al
et
al
ruohola
et
al
vergison
nevertheless
pathogenesi
aom
children
clearli
relat
acut
respiratori
viral
infect
arvi
variou
mean
facilit
transloc
pathogencontain
secret
inflam
nasopharynx
middl
ear
lieberth
et
al
mani
case
arvi
preced
aom
latter
consid
complic
arvi
chonmaitre
et
al
tradit
bacteri
viral
cultur
middl
ear
fluid
mef
use
establish
etiolog
aom
ensur
posit
rate
chonmaitre
lieberth
et
al
cultur
analysi
depend
viabl
microorgan
limit
sensit
labori
time
consum
princip
bacteri
otopathogen
pneumonia
h
influenza
belong
fastidi
microorgan
special
demand
plate
time
cultur
medium
may
preclud
proper
isol
speci
ueyama
et
al
advent
molecular
method
like
pcr
increas
preval
posit
mef
find
bacteri
pathogen
place
sever
new
virus
among
potenti
aom
pathogen
bulut
et
al
noksokoivisto
et
al
et
al
ruohola
et
al
ueyama
et
al
william
et
al
yano
et
al
systemat
use
tympanocentesi
advoc
current
clinic
practic
lieberth
et
al
restrict
avail
mef
monitor
etiolog
nonperfor
aom
impli
nph
secret
potenti
proxi
mef
inde
middl
ear
nasopharynx
find
compar
number
studi
indic
potenti
use
nasopharynx
examin
radzikowski
et
al
van
dongen
et
al
refer
therein
studi
employ
pcr
viru
detect
use
cultur
bacteri
isol
identif
present
work
use
seri
multiplex
realtim
pcr
detect
bacteri
viral
speci
mef
children
aom
diagnost
microbiolog
infecti
diseas
compar
pcr
result
cultur
select
bacteri
pathogen
moreov
assess
valu
pcr
find
nasopharynx
predict
pathogen
presenc
mef
aom
retrospect
studi
perform
use
biolog
specimen
obtain
children
year
age
aom
august
april
pediatr
hospit
moscow
russia
includ
children
diagnos
aom
otolaryngologist
mef
specimen
obtain
mayanskiy
et
al
diagnosi
aom
defin
otolaryngologist
patient
acut
ill
last
day
sign
physic
symptom
consist
aom
includ
earach
tug
ear
fever
red
bulg
tympanum
patient
receiv
antibiot
prior
enrol
spontan
tympanum
perfor
exclud
present
studi
mef
specimen
collect
otolaryngologist
tympanocentesi
swab
tympan
caviti
eswab
kit
copan
itali
procedur
perform
remov
debri
clean
extern
auditori
canal
lidocain
solut
ethyl
alcohol
exposur
minut
patient
contribut
aom
case
studi
bilater
aom
case
mef
specimen
obtain
ear
visit
nph
swab
collect
mean
eswab
kit
biolog
sampl
data
collect
accord
guidelin
hospit
ethic
committe
specimen
deliv
laboratori
scientif
center
children
health
moscow
process
within
hour
sampl
cultur
analys
specimen
store
room
temperatur
dark
place
bacteri
pathogen
includ
pneumonia
h
influenza
catarrhali
pyogen
staphylococcu
aureu
cultur
identifi
describ
earlier
mayanskiy
et
al
specimen
regard
cultur
posit
either
bacteria
alon
combin
isol
remain
specimen
frozen
store
use
molecular
assay
perform
central
research
institut
epidemiolog
moscow
russia
use
reagent
kit
manufactur
institut
supplement
kit
clear
vitro
diagnost
purpos
total
dna
rna
extract
aliquot
use
riboprep
nucleic
acid
extract
kit
elut
volum
elut
buffer
cdna
prepar
revers
transcript
rna
revert
rt
kit
pcr
dna
cdna
use
realtim
pcr
util
detect
bacteri
viral
nucleic
acid
na
rotorgen
instrument
corbett
research
sydney
australia
dna
pneumonia
h
influenza
pyogen
aureu
catarrhali
detect
quantit
manner
pyogen
aureu
analyz
use
streptococcu
pyogenesscreentitrefrt
pcr
kit
mrsascreentitrefrt
pcr
kit
respect
detect
remain
bacteria
use
pneumonia
gene
fragment
abdeldaim
et
al
h
influenza
hpd
gene
theodor
et
al
catarrhali
copb
gene
greiner
et
al
analyt
sensit
reaction
least
copi
dna
per
pcr
copiesml
everi
target
see
supplement
detail
realtim
pcr
result
consid
posit
lg
copiesml
dna
found
na
rest
respiratori
pathogen
detect
qualit
manner
identif
mycoplasma
pneumonia
chlamydophila
pneumonia
dna
done
amplisen
pneumoniaec
pneumoniaefrt
pcr
kit
viral
na
identif
includ
influenza
virus
b
use
amplisen
influenza
viru
abfrt
pcr
kit
enteroviru
use
amplisen
enterovirusfrt
pcr
kit
rsv
type
b
human
metapneumoviru
parainfluenzaviru
type
coronaviru
hrv
adv
type
b
c
e
human
bocaviru
use
amplisen
arviscreenfrt
pcr
kit
influenza
viru
c
gene
detect
realtim
rtpcr
see
supplement
detail
analyt
sensit
viral
na
pcr
test
least
copi
dnacdna
per
pcr
copiesml
everi
target
statist
analysi
perform
use
ibm
spss
statist
window
version
ibm
armonk
ny
usa
dna
load
differ
specimen
compar
mannwhitney
test
consid
statist
signific
p
b
sensit
specif
posit
neg
predict
valu
ppv
npv
respect
nph
pcr
result
predict
presenc
na
particular
respiratori
pathogen
mef
calcul
use
mef
specimen
pcr
result
refer
cramer
v
test
use
measur
strength
associ
pcr
result
mef
nasopharynx
particular
pathogen
test
may
valu
higher
valu
indic
stronger
associ
grjibovski
pcr
perform
total
mef
specimen
obtain
children
aom
patient
unilater
aom
patient
bilater
aom
contribut
mef
specimen
ear
median
patient
age
month
rang
month
year
na
least
pathogen
studi
eg
pcrposit
result
discov
children
overal
bacteri
pathogen
dna
alon
patient
dna
singl
speci
found
patient
wherea
dna
speci
found
patient
children
dna
speci
preval
organ
among
pathogen
studi
pneumonia
pneumococc
dna
found
patient
tabl
notic
preval
found
aureu
dna
detect
patient
howev
aureu
dna
alway
present
combin
na
pathogen
patient
aureu
dna
alon
mef
tabl
contrast
instanc
pneumococc
dna
na
found
pneumonia
dnaposit
patient
dna
pneumonia
c
pneumonia
found
mef
patient
pair
mef
specimen
obtain
children
bilater
aom
n
pcr
result
almost
complet
agre
patient
dna
h
influenza
n
rna
hrv
n
mixtur
na
aureu
hrv
n
discov
ear
addit
pneumonia
dna
found
ear
viral
na
present
children
although
patient
viral
na
alon
repres
hrv
n
adv
n
tabl
mixtur
bacteri
viral
na
observ
children
highest
discoveri
rate
regist
hrv
rna
adv
dna
detect
mef
children
respect
tabl
na
rsv
influenza
viru
type
c
human
bocaviru
found
rare
patient
exclus
combin
dna
bacteri
pathogen
na
influenza
viru
type
b
parainfluenzaviru
human
metapneumoviru
enteroviru
coronaviru
found
mef
next
compar
pcr
cultur
result
bacteri
pathogen
consid
specimen
level
tabl
bacteri
dna
found
mef
specimen
wherea
cultureposit
result
observ
specimen
thu
overal
rate
pcrposit
specimen
bacteri
pathogen
time
higher
confidenti
interv
ci
time
differ
detect
rate
pcr
cultur
pathogenspecif
manner
biggest
gap
observ
h
influenza
found
time
ci
time
often
pcr
cultur
rest
bacteri
pathogen
studi
ratio
pcrpositivecultureposit
specimen
vari
tabl
overal
median
dna
load
culturepositivepcrposit
mef
specimen
close
lg
copiesml
bacteri
pathogen
except
catarrhali
median
dna
load
lg
copiesml
tabl
median
dna
concentr
pneumonia
pyogen
aureu
significantli
higher
least
lg
copiesml
ie
time
culturepositivepcrposit
specimen
cultureposit
specimen
minimum
load
aureu
dna
lg
copiesml
valu
lg
copiesml
higher
compar
bacteria
tabl
valu
nph
pcr
result
predict
presenc
pathogen
middl
ear
nph
specimen
obtain
patient
enrol
studi
n
overal
rate
pcrposit
nph
specimen
bacteri
dna
detect
specimen
patient
pneumonia
dna
detect
associ
dna
pneumonia
none
patient
carri
dna
c
pneumonia
nasopharynx
median
load
dna
nph
mef
specimen
similar
bacteri
pathogen
except
catarrhali
approxim
lg
copiesml
abund
nasopharynx
tabl
virus
detect
nph
specimen
highest
preval
found
hrv
adv
tabl
na
influenza
viru
metapneumoviru
coronaviru
enteroviru
detect
nasopharynx
strength
agreement
pcr
result
pair
mef
nph
specimen
assess
use
cramer
v
test
grjibovski
strong
associ
mef
nph
pcr
result
v
n
observ
pneumonia
h
influenza
adv
tabl
remain
microorgan
demonstr
substanti
proport
discord
pcr
result
lower
vvalu
tabl
next
analyz
predict
valu
nph
pcr
result
presenc
na
certain
microorgan
mef
posit
nph
pcr
result
modest
low
ppv
except
pneumonia
recov
pneumococc
dna
nasopharynx
increas
chanc
posit
pcr
result
pneumococc
dna
mef
ppv
tabl
lowest
vvalu
ppv
obtain
catarrhali
respect
aureu
respect
specif
npv
nph
pcr
find
high
tabl
instanc
npv
neg
nph
result
pneumococc
dna
indic
chanc
find
dna
mef
reduc
valu
correspond
preval
mef
see
tabl
ie
npv
present
nasopharynx
present
studi
perform
pcr
analysi
broad
rang
respiratori
pathogen
mef
nph
specimen
obtain
children
aom
knowledg
first
comprehens
sum
overal
proport
pathogen
exceed
patient
combin
pathogen
recov
adv
adenoviru
includ
type
b
c
e
infc
influenza
viru
type
c
hbov
human
bocaviru
rsv
respiratori
syncyti
viru
includ
type
b
valu
boldfac
indic
number
patient
correspond
pathogen
detect
singli
mef
percentag
bracket
repres
ratio
singli
detect
pathogen
overal
preval
pathogen
studi
enrol
signific
number
patient
elabor
etiolog
aom
use
parallel
pcr
mef
nasopharynx
comparison
pcr
cultur
demonstr
higher
sensit
molecular
method
detect
bacteri
pathogen
increas
sensit
pcr
may
attribut
least
part
fact
pcr
depend
bacteri
viabil
special
import
fastidi
otopathogen
like
pneumonia
h
influenza
result
correspond
earlier
report
demonstr
patient
otiti
media
pcr
sensit
convent
cultur
method
detect
mef
h
influenza
least
time
ueyama
et
al
anoth
explan
cultur
negativepcrposit
result
could
presenc
noncultur
bacteria
remain
mef
previou
aom
episod
palmu
et
al
howev
nonviabl
bacteria
dna
dead
bacteria
may
resid
mef
longer
day
effici
elimin
middl
ear
post
et
al
instead
mefdetect
dna
may
origin
nasopharynx
continu
feed
dnacontain
media
moreov
presenc
bacteri
biofilm
propos
reason
cultur
failur
posit
pcr
result
ehrlich
et
al
palmu
et
al
pcr
analys
support
etiolog
role
aom
atyp
bacteria
like
pneumonia
chlamydophila
spp
detect
mef
patient
corrobor
previou
report
never
demonstr
presenc
pneumonia
mef
et
al
rosenblut
et
al
occasion
found
chlamydophila
spp
aom
patient
mainli
epidem
elev
preval
block
et
al
falck
et
al
reportedli
preval
distribut
virus
mef
consist
vari
differ
studi
set
geograph
region
season
detect
methoddepend
fluctuat
sever
report
finland
detect
rate
virus
mef
predomin
picornavirus
hrv
enterovirus
noksokoivisto
et
al
et
al
ruohola
et
al
studi
unit
state
identifi
virusposit
aom
patient
rsv
mef
heikkinen
et
al
turkish
report
respiratori
viru
found
mef
aom
patient
rsv
hrv
highest
identif
rate
among
virusposit
patient
respect
bulut
et
al
viru
detect
rate
much
lower
paper
japan
identifi
respiratori
virus
aom
patient
cultur
almost
half
detect
virus
repres
rsv
yano
et
al
similar
result
observ
studi
chile
children
aom
viru
mef
rosenblut
et
al
patient
cohort
hrv
adv
somewhat
appreci
represent
mef
cover
collect
virusposit
patient
rsv
consist
detect
one
abund
virus
mef
patel
et
al
found
patient
combin
h
influenza
find
correspond
low
incid
rsv
infect
studi
period
russia
estim
acut
respiratori
infect
visit
iatsyshina
et
al
role
respiratori
virus
develop
aom
discuss
sever
interest
paper
chonmaitre
et
al
heikkinen
chonmaitre
noksokoivisto
et
al
clinic
evid
arvi
shown
associ
increas
risk
aom
involv
wide
rang
mechan
although
signific
virus
develop
aom
suggest
chinchilla
model
vivo
bakaletz
et
al
import
independ
etiolog
agent
remain
controversi
viral
infect
facilit
passag
bacteri
pathogen
nasopharynx
middl
ear
support
progress
clinic
ill
aom
lieberth
et
al
moreov
respiratori
virus
particularli
hrv
promot
spread
bacteri
agent
among
human
popul
may
produc
imbal
nph
microbiota
enhanc
prolifer
pneumonia
h
influenza
heikkinen
chonmaitre
similarli
present
result
favor
direct
role
respiratori
virus
develop
aom
demonstr
major
patient
aom
low
preval
virus
conjunct
presenc
signific
bacteri
otopathogen
mef
nasopharynx
ppv
nph
specimen
examin
pcr
discov
consider
pathogendepend
variabl
highest
ppv
found
pneumonia
preval
pathogen
aureu
catarrhali
demonstr
low
ppv
weak
associ
mef
nph
pcr
result
high
proport
mefneg
nphposit
result
remark
aureu
dna
alway
detect
combin
na
catarrhali
dna
preval
nasopharynx
middl
ear
data
may
suggest
speci
like
colon
tabl
valu
pcr
result
nasopharynx
predict
presenc
pathogen
middl
ear
overal
nasopharynx
n
number
bacteri
pathogen
isol
test
indic
tabl
mef
specimen
column
pcr
posit
tabl
nph
specimen
column
overal
nasopharynx
nasopharynx
serv
primari
caus
clinic
infect
middl
ear
thu
gener
nph
pcr
result
reliabl
exclud
presenc
respiratori
pathogen
na
mef
consist
high
npv
suggest
nph
pcr
result
neg
particular
na
na
unlik
detect
mef
aom
patient
note
overal
concord
mef
nph
pcr
result
ie
proport
specimen
pcr
result
nasopharynx
mef
high
rang
howev
diagnost
signific
agreement
limit
due
larg
number
neg
concord
result
least
preval
pathogen
like
virus
quantit
realtim
pcr
multiplex
detect
five
bacteri
speci
use
assess
associ
mef
nph
microbiota
aom
patient
studi
evalu
concord
mef
nph
find
use
convent
cultur
wherea
pcr
employ
paper
analysi
narrow
set
speci
eser
et
al
ueyama
et
al
van
dongen
et
al
overal
result
report
literatur
demonstr
modest
low
ppv
around
relev
microb
moder
high
npv
rang
van
dongen
et
al
present
studi
observ
higher
ppv
pneumonia
h
influenza
previous
report
suggest
better
perform
pcr
method
predict
mef
find
limit
present
studi
need
mention
first
patient
cohort
includ
children
requir
tympanocentesi
may
bias
sampl
toward
sever
aom
thu
disturb
pathogen
distribut
increas
proport
detect
bacteria
expens
virus
next
examin
patient
spontan
otorrhea
may
aggress
aom
cours
associ
bacteria
like
pyogen
final
swab
tympan
caviti
tympanocentesi
could
less
effect
compar
aspir
mef
term
collect
detect
amount
viral
pathogen
taken
togeth
result
indic
multiplex
realtim
pcr
reason
approach
detect
respiratori
pathogen
patient
aom
use
mef
specimen
refer
demonstr
parallel
pcr
examin
nph
specimen
provid
use
inform
mef
pathogen
high
predict
valu
exclud
pathogen
investig
nph
microbiota
could
reliabl
proxi
mef
examin
epidemiolog
studi
trial
look
potenti
benefit
new
vaccin
respiratori
pathogen
addit
pcr
analysi
nph
specimen
could
help
predict
bacteri
complic
arvi
instanc
aom
conclus
implement
sensit
rapid
multiplex
molecular
method
would
extend
understand
respiratori
pathogen
interplay
improv
diagnost
respiratori
infect
none
